Yakob Liawatidewi is EVP CORP ADMIN CENTER of Amphastar Pharmaceuticals, Inc.. Currently has a direct ownership of 74,938 shares of AMPH, which is worth approximately $2.61 Million. The most recent transaction as insider was on Nov 06, 2024, when has been sold 5,214 shares (Common Stock) at a price of $52.05 per share, resulting in proceeds of $271,388. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 74.9K
0% 3M change
7.56% 12M change
Total Value Held $2.61 Million

Yakob Liawatidewi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 06 2024
SELL
Open market or private sale
$271,388 $52.05 p/Share
5,214 Reduced 6.51%
74,938 Common Stock
Nov 06 2024
BUY
Exercise of conversion of derivative security
$67,938 $13.03 p/Share
5,214 Added 6.11%
80,152 Common Stock
Jun 04 2024
SELL
Payment of exercise price or tax liability
$11,483 $42.22 p/Share
272 Reduced 0.36%
74,938 Common Stock
Mar 17 2024
SELL
Payment of exercise price or tax liability
$74,304 $43.05 p/Share
1,726 Reduced 2.26%
74,778 Common Stock
Mar 16 2024
SELL
Payment of exercise price or tax liability
$71,936 $43.05 p/Share
1,671 Reduced 2.14%
76,504 Common Stock
Mar 15 2024
SELL
Payment of exercise price or tax liability
$44,212 $43.05 p/Share
1,027 Reduced 1.3%
78,175 Common Stock
Mar 06 2024
SELL
Payment of exercise price or tax liability
$56,544 $46.31 p/Share
1,221 Reduced 1.52%
79,202 Common Stock
Mar 04 2024
BUY
Grant, award, or other acquisition
-
10,754 Added 11.79%
80,423 Common Stock
Aug 28 2023
SELL
Open market or private sale
$1,530,994 $53.13 p/Share
28,816 Reduced 29.26%
69,669 Common Stock
Aug 28 2023
BUY
Exercise of conversion of derivative security
$482,379 $16.74 p/Share
28,816 Added 22.64%
98,485 Common Stock
Jun 04 2023
SELL
Payment of exercise price or tax liability
$17,652 $46.7 p/Share
378 Reduced 0.54%
69,669 Common Stock
Apr 13 2023
SELL
Open market or private sale
$477,001 $41.5 p/Share
11,494 Reduced 14.24%
69,215 Common Stock
Apr 13 2023
BUY
Exercise of conversion of derivative security
$232,523 $20.23 p/Share
11,494 Added 12.47%
80,709 Common Stock
Apr 10 2023
SELL
Open market or private sale
$200,000 $40.0 p/Share
5,000 Reduced 6.74%
69,215 Common Stock
Apr 10 2023
BUY
Exercise of conversion of derivative security
$101,150 $20.23 p/Share
5,000 Added 6.31%
74,215 Common Stock
Mar 17 2023
SELL
Payment of exercise price or tax liability
$60,713 $36.29 p/Share
1,673 Reduced 2.36%
69,215 Common Stock
Mar 16 2023
SELL
Payment of exercise price or tax liability
$60,912 $37.6 p/Share
1,620 Reduced 2.23%
70,888 Common Stock
Mar 15 2023
SELL
Payment of exercise price or tax liability
$68,190 $36.84 p/Share
1,851 Reduced 2.49%
72,508 Common Stock
Mar 06 2023
BUY
Grant, award, or other acquisition
-
12,752 Added 14.64%
74,359 Common Stock
Aug 09 2022
SELL
Open market or private sale
$119,145 $39.0 p/Share
3,055 Reduced 4.72%
61,607 Common Stock
Aug 09 2022
BUY
Exercise of conversion of derivative security
$60,458 $19.79 p/Share
3,055 Added 4.51%
64,662 Common Stock
Aug 08 2022
SELL
Open market or private sale
$190,000 $38.0 p/Share
5,000 Reduced 7.51%
61,607 Common Stock
Aug 08 2022
BUY
Exercise of conversion of derivative security
$98,950 $19.79 p/Share
5,000 Added 6.98%
66,607 Common Stock
Jul 15 2022
SELL
Open market or private sale
$395,117 $36.46 p/Share
10,837 Reduced 14.96%
61,607 Common Stock
Jul 15 2022
BUY
Exercise of conversion of derivative security
$214,464 $19.79 p/Share
10,837 Added 13.01%
72,444 Common Stock
YL

Yakob Liawatidewi

EVP CORP ADMIN CENTER
Rancho Cucamonga, CA

Track Institutional and Insider Activities on AMPH

Follow Amphastar Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMPH shares.

Notify only if

Insider Trading

Get notified when an Amphastar Pharmaceuticals, Inc. insider buys or sells AMPH shares.

Notify only if

News

Receive news related to Amphastar Pharmaceuticals, Inc.

Track Activities on AMPH